[59] Rep. Smith: Enforcing the prevention of synthetic drug sales is essential (9/6/2012)

Thursday, September 6, 2012

Start Date: 9/6/2012 Start Time: 12:00 PM
End Date: 9/6/2012 End Time: 12:00 PM
STATEHOUSE- Yesterday, September 5, a press conference was held by Marion County Prosecutor Terry Curry and Indiana Attorney General Greg Zoeller to discuss the launch of local and statewide initiatives aimed at getting synthetic drugs like “bath salts” and “spice” off retail store shelves.

According to a recently enacted state law House Bill 1196, authored by Rep. Milo Smith (R-Columbus), retail merchants, convenience stores and gas stations caught selling the synthetic drugs face penalties including criminal charges and the loss of their retail merchant certificate of business for one year.
“It is of the upmost importance to safeguard our communities from harmful drugs and criminal activity,” said Rep. Smith. “Retailers need to be completely aware that their compliance with this matter is taken very seriously by all levels of government.

“Bath salts have claimed too many teenage lives, and we must do more to prevent these drugs from being sold by retail stores.”

Synthetic drugs are made to mirror the effects of marijuana or cocaine, but sold openly under the guise of “plant food,” “bath salts,” “potpourri,” “incense” or “spice.” While the packaging is labeled not for human consumption, the products are often taken orally, inhaled or injected.
“This collaborative effort between state and local officials is intended to send a strong message to businesses that continue to sell synthetic drugs despite the law and the risk to the public,” said Attorney General Zoeller.

The purpose of yesterday’s press conference was to notify business owners of the penalties and consequences for legal violations in relation to synthetic drug production and distribution. For more information or questions, please visit the Attorney General’s webpage at www.AttorneyGeneral.IN.gov or call (317)232-6201.


Rep. Smith. Enforcing the prevention of synthetic drug sales.docx